This cooperative nature between Apc and KRAS mutations in leading to increased tumor formation is similar to that observed in two previous studies, one involving Apc+/1638/KRASV12 double transgenic mice [42] and the other ApcMin/K-rasD12 double transgenic mice [43]. The gene discussed is KRAS; the disease is neoplasm.